These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 33867405)

  • 1. Primary Graft Dysfunction After Isolated Heart Transplantation　- Incidence, Risk Factors, and Clinical Implications Based on a Single-Center Experience.
    Rhee Y; Kim HJ; Kim JJ; Kim MS; Lee SE; Yun TJ; Lee JW; Jung SH
    Circ J; 2021 Aug; 85(9):1451-1459. PubMed ID: 33867405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, predictors, and outcomes after severe primary graft dysfunction in pediatric heart transplant recipients.
    Profita EL; Gauvreau K; Rycus P; Thiagarajan R; Singh TP
    J Heart Lung Transplant; 2019 Jun; 38(6):601-608. PubMed ID: 30733156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracorporeal life support for primary graft dysfunction after heart transplantation.
    Pozzi M; Bottin C; Armoiry X; Sebbag L; Boissonnat P; Hugon-Vallet E; Koffel C; Flamens C; Paulus S; Fellahi JL; Obadia JF
    Interact Cardiovasc Thorac Surg; 2018 Nov; 27(5):778-784. PubMed ID: 29788286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Factors for Severe Primary Graft Dysfunction in Infants Following Heart Transplant.
    Singh TP; Profita EL; Rycus P; Thiagarajan R; Gauvreau K
    J Am Heart Assoc; 2021 Jul; 10(13):e021082. PubMed ID: 34184543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the International Society for Heart and Lung Transplantation primary graft dysfunction instrument in heart transplantation.
    Foroutan F; Alba AC; Stein M; Krakovsky J; Chien KGW; Chih S; Guyatt G; Ross H
    J Heart Lung Transplant; 2019 Mar; 38(3):260-266. PubMed ID: 30642796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of the International Society for Heart and Lung Transplantation (ISHLT) criteria for primary graft dysfunction after cardiac transplantation: outcomes from a high-volume centre†.
    Squiers JJ; Saracino G; Chamogeorgakis T; MacHannaford JC; Rafael AE; Gonzalez-Stawinski GV; Hall SA; DiMaio JM; Lima B
    Eur J Cardiothorac Surg; 2017 Feb; 51(2):263-270. PubMed ID: 28186268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recipient and surgical factors trigger severe primary graft dysfunction after heart transplant.
    Benck L; Kransdorf EP; Emerson DA; Rushakoff J; Kittleson MM; Klapper EB; Megna DJ; Esmailian F; Halprin C; Trento A; Ramzy D; Czer LSC; Chang DH; Ebinger JE; Kobashigawa JA; Patel JK
    J Heart Lung Transplant; 2021 Sep; 40(9):970-980. PubMed ID: 34272125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ISHLT Primary Graft Dysfunction Incidence, Risk Factors, and Outcome: A UK National Study.
    Avtaar Singh SS; Banner NR; Rushton S; Simon AR; Berry C; Al-Attar N
    Transplantation; 2019 Feb; 103(2):336-343. PubMed ID: 29757910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracorporeal membrane oxygenation as a salvage therapy for patients with severe primary graft dysfunction after heart transplant.
    Jacob S; Lima B; Gonzalez-Stawinski GV; El-Sayed Ahmed MM; Patel PC; Belli EV; Makey IA; Thomas M; Landolfo K; Landolfo C; Leoni Moreno JC; Yip DS; Pham SM
    Clin Transplant; 2019 May; 33(5):e13538. PubMed ID: 30870577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes of patients with primary graft dysfunction after cardiac transplantation.
    Squiers JJ; DiMaio JM; Van Zyl J; Lima B; Gonzalez-Stawisnksi G; Rafael AE; Meyer DM; Hall SA
    Eur J Cardiothorac Surg; 2021 Nov; 60(5):1178-1183. PubMed ID: 34100537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe and Moderate Primary Graft Dysfunction in Adult Heart Recipients.
    Stefen SP; Tenório DF; Cirillo GCG; Gaspar SF; Oliveira KAS; Gaiotto FA; Jatene FB
    Braz J Cardiovasc Surg; 2023 Apr; 38(2):214-218. PubMed ID: 36592073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of primary graft dysfunction after heart transplantation.
    Settepani F; Pedrazzini GL; Olivieri GM; Merlanti B; Cannata A; Lanfranconi M; Frigerio M; Russo CF
    J Card Surg; 2022 May; 37(5):1290-1298. PubMed ID: 35229361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of High-Sensitivity Troponin-T to Identify Patients at Risk of Left Ventricular Graft Dysfunction After Heart Transplantation.
    Méndez AB; Ordonez-Llanos J; Mirabet S; Galan J; Maestre ML; Brossa V; Rivilla MT; López L; Koller T; Sionis A; Roig E
    Transplant Proc; 2016 Nov; 48(9):3021-3023. PubMed ID: 27932136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of severe primary graft dysfunction in patients bridged to heart transplantation with continuous-flow left ventricular assist devices.
    Truby LK; Takeda K; Topkara VK; Takayama H; Garan AR; Yuzefpolskaya M; Colombo P; Naka Y; Farr M
    J Heart Lung Transplant; 2018 Dec; 37(12):1433-1442. PubMed ID: 30206023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case series: the outcomes, support duration, and graft function recovery after VA-ECMO use in primary graft dysfunction after heart transplantation.
    Kawabori M; Mastroianni MA; Zhan Y; Chen FY; Rastegar H; Warner KG; Reich JA; Vest A; DeNofrio D; Couper GS
    J Artif Organs; 2020 Jun; 23(2):140-146. PubMed ID: 31713054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor hyperoxia is a novel risk factor for severe cardiac primary graft dysfunction.
    Kransdorf EP; Rushakoff JA; Han J; Benck L; Malinoski D; Emerson D; Catarino P; Rampolla R; Kobashigawa JA; Khush KK; Patel JK
    J Heart Lung Transplant; 2023 May; 42(5):617-626. PubMed ID: 36682894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic profiling identifies CLEC4C expression as a novel biomarker of primary graft dysfunction after heart transplantation.
    Truby LK; Kwee LC; Agarwal R; Grass E; DeVore AD; Patel CB; Chen D; Schroder JN; Bowles D; Milano CA; Shah SH; Holley CL
    J Heart Lung Transplant; 2021 Dec; 40(12):1589-1598. PubMed ID: 34511330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and impact of primary graft dysfunction in adult heart transplant recipients: A systematic review and meta-analysis.
    Buchan TA; Moayedi Y; Truby LK; Guyatt G; Posada JD; Ross HJ; Khush KK; Alba AC; Foroutan F
    J Heart Lung Transplant; 2021 Jul; 40(7):642-651. PubMed ID: 33947602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved outcomes from extracorporeal membrane oxygenation versus ventricular assist device temporary support of primary graft dysfunction in heart transplant.
    Takeda K; Li B; Garan AR; Topkara VK; Han J; Colombo PC; Farr MA; Naka Y; Takayama H
    J Heart Lung Transplant; 2017 Jun; 36(6):650-656. PubMed ID: 28087104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence, etiology, and outcome of primary graft dysfunction in adult heart transplant recipients: a single-center experience in Japan.
    Seguchi O; Fujita T; Murata Y; Sunami H; Sato T; Watanabe T; Nakajima S; Kuroda K; Hisamatsu E; Sato T; Yanase M; Hata H; Wada K; Ishibashi-Ueda H; Kobayashi J; Nakatani T
    Heart Vessels; 2016 Apr; 31(4):555-62. PubMed ID: 25682298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.